Avoca, a WCG company

Webinar: ICH E6(R3): How to prepare when you’re still struggling to adopt ICH E6(R2)

May 5, 2020 | 11:00am – 12:00pm EDT
The Final Concept Paper for ICH E6(R3), dated 17 November 2019, states, “The action proposed is a full rewrite and reorganization of the ICH E6(R2) Guideline….and will include addressing the application of GCP principles to the increasingly diverse trial types and the data sources being employed to support regulatory and healthcare-related decision-making on drugs, and provide flexibility whenever appropriate to facilitate the use of technological innovations in clinical trials.”

ACRP 2020: Signature Series (Postponed)

May 2, 2020 | Seattle, WA
Women in Leadership: Chutes, Ladders, and Unexpected Journeys - Executive leadership from Juno Therapeutics, Genentech, IQVIA, The Avoca Group, and Javara Research will share their career journeys and host an honest conversation about what it takes to advance as a woman in research.

ACRP-Avoca Quality Congress (Postponed)

May 1, 2020 | Seattle, WA
Adding Electricity to Patient Centricity: Energizing Solutions - Join patients and executive leadership from sponsors, CROs, sites, and technology suppliers in a collaborative, solutions-focused discussion of the patient centricity landscape. Industry leadership will unveil recent trends in the use of patient-centric tools and technologies and lead an […]

Avoca Quality Consortium Open Mic – Provider Qualification (AQC Members only)

April 9, 2020 | 11:00am – 12:00pm EDT
Join Janis Hall, AQC Leadership Advisory Board Members, and fellow AQC Members for the AQC’s first Open Mic session where we will answer questions about Provider Qualification, such as, “What do you share with regulatory inspectors when asked to show evidence of provider prequalification?” and […]

Virtual Meeting: Innovative Solutions to Provider Qualification Challenges

April 6, 2020

COVID-19 CEO Letter

March 25, 2020 – This is an update on how we are addressing the needs of Avoca’s clients and Quality Consortium Members, and the companies that we are working with as part of the Diligent® Qualification Platform, given the extraordinary circumstances that we face with COVID-19. The Avoca Group Operations Avoca and its global team of experts have […]

News Release: CRO and Sponsor Quality Award Finalists Announced by ACRP, The Avoca Group

March 6, 2020
Washington, DC – The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP Awards & Recognition Ceremony on Friday, May 1, during the ACRP 2020 annual conference in Seattle, Washington.

Article: Clinical Development Vendor Qualification: “Check-The-Box” Exercise?

March 4, 2020 – Contract Pharma – Jay A. Turpen, Senior Consultant, The Avoca Group – Key first steps to vendor risk management. Are your company’s clinical development vendor qualification (VQ) activities a “Check-The-Box” exercise because someone said that regulators expect it? Or are your VQ activities a comprehensive first step in managing the risk […]

« Older posts

Newer posts »

News & Industry-wide Events